Regulation of Anti-Malarial Commodities with a focus on Artemisinin-Combination Therapy in Asia and Pacific

  • Home
  • -
  • Research & Consulting
  • -
  • Regulation of Anti-Malarial Commodities with a focus on Artemisinin-Combination Therapy in Asia and Pacific

Regulation of Anti-Malarial Commodities with a focus on Artemisinin-Combination Therapy in Asia and Pacific

The Asia Pacific region has been facing a big challenge of resistance to oral artemisinin-based combination therapies. Empower School of Health has written a recommendations paper for APLMA (funded by ADB) highlighting various interventions to counter this situation, based on improving product quality, strong enforcement of regulations, and building consumer awareness.

Be among the first to hear about our upcoming training programs, projects and other events.